Computational drug–drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel
Ilaprazole due to its pharmacokinetic variability does not affect the clopidogrel efficacy during concomitant use. Methodology: Prediction of DDI for Clopidogrel and PPIs performed using (DDI-Pred) Way2Drug software. The probabilities ΔP, which estimate the potential DDIs resulting from interaction...
Saved in:
| Main Authors: | Priyadharshini Ananthathandavan, Damodharan Narayanasamy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.2144/fsoa-2023-0277 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ilaprazole: Distinctive pharmacokinetic and pharmacodynamic properties among proton pump inhibitors
by: Hubert Igno Castus, et al.
Published: (2025-07-01) -
Targeted but Troubling: CYP450 Inhibition by Kinase and PARP Inhibitors and Its Clinical Implications
by: Martin Kondža, et al.
Published: (2025-05-01) -
PHARMACOGENETICS OF ANTITHROMBOTIC DRUGS: STATUS UPDATE ON THE PROBLEM
by: Ekaterina S. Kropacheva
Published: (2018-12-01) -
Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats
by: V. P. Zherdev, et al.
Published: (2017-11-01) -
CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME PATIENTS WITH CYP2Y12*2 AND CYP2Y12*3 POLYMORPHISMS
by: R. Rahmatini, et al.
Published: (2018-04-01)